Anti-Factor VIII Anticorps [RFF-VIIIC/5] (A281667)

Anti-Factor VIII Antibody [RFF-VIIIC/5]

Mouse monoclonal [RFF-VIIIC/5] antibody to Factor VIII.

This antibody recognises human Factor VIII, an essential blood coagulation factor. Factor VIII is primarily synthesized in the liver and is secreted into the bloodstream where it forms a complex with von Willebrand factor. It is activated through cleavage at various sites, dissociates from the complex and interacts with Factor IXa, in the presence of calcium ions and phospholipids, to convert Factor X to the activated Factor Xa, which in turn activates thrombin. Thrombin cleaves fibrinogen into fibrin, which polymerises and cross-links to form a blood clot. The activated Factor VIII is proteolytically inactivated and cleared from the bloodstream. Defects in Factor VIII cause haemophilia A (HEMA), a disorder characterised by the body’s inability to control blood clotting, potentially resulting in severe blood loss, even with minor injuries. recognises an epitope towards the C-terminus of full-length Factor VIII. It also recognises the ~80 kDa and ~70 kDa cleavage products.

WB, ELISA, RIA

ELISA: 1:400 - 1:4,000

Human

Affinity purified human Factor VIII.

Mouse

Monoclonal

RFF-VIIIC/5

IgG1

Unconjugated

1 mg/ml

Liquid

Supplied in Phosphate Buffered Saline with 0.09% Sodium Azide.

Shipped at ambient temperature. Upon delivery aliquot and store at -20°C. When thawed, aliquot the sample as needed. Short term (up to 4 weeks): store at 4°C. Long term: store at -20°C. Avoid freeze / thaw cycles. Storage in frost free freezers is not recommended.

Mouse anti Human Factor VIII antibody, clone RFF-VIIIC/5 recognizes human Factor VIII, an essential blood coagulation factor. Factor VIII is primarily synthesized in the liver and is secreted into the bloodstream where it forms a complex with von Willebrand factor. It is activated through cleavage at various sites, dissociates from the complex and interacts with Factor IXa, in the presence of calcium ions and phospholipids, to convert Factor X to the activated Factor Xa, which in turn activates thrombin. Thrombin cleaves fibrinogen into fibrin, which polymerises and cross-links to form a blood clot. The activated Factor VIII is proteolytically inactivated and cleared from the bloodstream. Defects in Factor VIII cause haemophilia A (HEMA), a disorder characterised by the body’s inability to control blood clotting, potentially resulting in severe blood loss, even with minor injuries. Mouse anti Human Factor VIII antibody, clone RFF-VIIIC/5 recognizes an epitope towards the C-terminus of full-length Factor VIII. It also recognizes the ~80 kDa and ~70 kDa cleavage products.

AHF, Antihemophilic factor, Coagulation factor VIII, coagulation factor VIII, procoagulant component, coagulation factor VIIIc, DXS1253E, F8, F8b, F8c, FA8_HUMAN, factor VIII F8B, Factor VIIIa light chain, FactorVIII, FVIII, Hema, Hemophilia A, Hemophilia, classic, OTTHUMP00000061446, OTTHUMP00000196174, Procoagulant component